Literature DB >> 29890171

Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy.

Robert F Kushner1.   

Abstract

Obesity is one of the most serious and prevalent non-communicable diseases of the twenty-first century. It is also a patient-centered condition in which affected individuals seek treatment through a variety of commercial, medical and surgical approaches. Considering obesity as a chronic medical disease state helps to frame the concept of using a three-stepped intensification of care approach to weight management. As a foundation, all patients should be counseled on evidence-based lifestyle approaches that include diet, physical activity and behavior change therapies. At the second tier, four new pharmacological agents, lorcaserin, phentermine/topiramate, naltrexone/bupropion and liraglutide have been approved since 2012 as adjuncts to lifestyle modification. The third step, bariatric surgery, has been demonstrated to be the most effective and long-term treatment for individuals with severe obesity or moderate obesity complicated by co-morbid conditions that is not responsive to non-surgical approaches. By using a medical model, clinicians can provide more proactive and effective treatments in assisting their patients with weight loss.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diet; Lifestyle; Obesity; Pharmacology

Mesh:

Substances:

Year:  2018        PMID: 29890171     DOI: 10.1016/j.pcad.2018.06.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  16 in total

1.  Loss of Uncoupling Protein 3 Attenuates Western Diet-Induced Obesity, Systemic Inflammation, and Insulin Resistance in Rats.

Authors:  Tyler M Lomax; Sadia Ashraf; Gizem Yilmaz; Romain Harmancey
Journal:  Obesity (Silver Spring)       Date:  2020-07-27       Impact factor: 5.002

2.  Weight loss and high-protein, high-fiber diet consumption impact blood metabolite profiles, body composition, voluntary physical activity, fecal microbiota, and fecal metabolites of adult dogs.

Authors:  Thunyaporn Phungviwatnikul; Anne H Lee; Sara E Belchik; Jan S Suchodolski; Kelly S Swanson
Journal:  J Anim Sci       Date:  2022-02-01       Impact factor: 3.159

3.  The Social Problems of Morbidly Obese Patients on a Community Level: A Cross-Sectional Study in Saudi Arabia.

Authors:  Albaraa H Kazim; Afnan Mohammed Al-Ruwaybiah; Mohammed Y Al-Naami; Abdullah Aldohayan; Ahmed A Binjaloud; Mosab A Alarfaj
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-15       Impact factor: 3.249

4.  Modified Peptide YY Molecule Attenuates the Activity of NPY/AgRP Neurons and Reduces Food Intake in Male Mice.

Authors:  Edward S Jones; Nicolas Nunn; Adam P Chambers; Søren Østergaard; Birgitte S Wulff; Simon M Luckman
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

5.  Impact of anti-obesity medication initiation and duration on weight loss in a comprehensive weight loss programme.

Authors:  R Safavi; A Lih; S Kirkpatrick; S Haller; M R Bailony
Journal:  Obes Sci Pract       Date:  2019-08-12

6.  Caloric restriction and Roux-en-Y Gastric Bypass promote white adipose tissue browning in mice.

Authors:  D Huang; Z Zhang; Z Dong; R Liu; J Huang; G Xu
Journal:  J Endocrinol Invest       Date:  2021-07-07       Impact factor: 4.256

7.  The first survey addressing patients with BMI over 50: a survey of 789 bariatric surgeons.

Authors:  Mohammad Kermansaravi; Panagiotis Lainas; Shahab Shahabi Shahmiri; Wah Yang; Amirhossein Davarpanah Jazi; Ramon Vilallonga; Luciano Antozzi; Chetan Parmar; Radwan Kassir; Sonja Chiappetta; Lorea Zubiaga; Antonio Vitiello; Kamal Mahawar; Miguel Carbajo; Mario Musella; Scott Shikora
Journal:  Surg Endosc       Date:  2022-01-21       Impact factor: 3.453

Review 8.  Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass.

Authors:  Blandine Laferrère; François Pattou
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-10       Impact factor: 5.555

9.  Effects of Socioeconomic Status on Physical and Psychological Health: Lifestyle as a Mediator.

Authors:  Jian Wang; Liuna Geng
Journal:  Int J Environ Res Public Health       Date:  2019-01-20       Impact factor: 3.390

10.  The Appetite Suppressant D-norpseudoephedrine (Cathine) Acts via D1/D2-Like Dopamine Receptors in the Nucleus Accumbens Shell.

Authors:  B Kalyanasundar; Claudia I Perez; Benjamin Arroyo; Mario Gil Moreno; Ranier Gutierrez
Journal:  Front Neurosci       Date:  2020-10-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.